Revision: Jan. 4, 2021, 3:02 p.m.
HB 201 - AS INTRODUCED
2021 SESSION
21-0385
10/06
HOUSE BILL 201
SPONSORS: Rep. McBeath, Rock. 26
COMMITTEE: Commerce and Consumer Affairs
-----------------------------------------------------------------
ANALYSIS
This bill requires the commissioner of insurance to review the implementation of the requirement for coverage of pediatric autoimmune neuropsychiatric disorders as adopted by 2019, 277 (SB 244-FN) and to report to the legislature.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
21-0385
10/06
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty One
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Insurance; Certain Biologically-based Mental Illnesses; Pediatric Autoimmune Neuropsychiatric Disorders; Review and Report. The commissioner of the insurance department shall review the implementation of the requirement in RSA 417-E:1, II as amended by 2018, 277 to provide insurance coverage for pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician. Following such review, the commissioner shall issue a report, not later than November 1, 2021, to the chairpersons of the house and senate standing committees with jurisdiction over insurance matters.
2 Effective Date. This act shall take effect upon its passage.